Ray joined Sofinnova as Portfolio Manager of the Synergy Fund in 2022. He focuses on Biotechnology and Therapeutics and has 13 years of investing experience and 19 years of sector-specific analytical experience.
Before joining Sofinnova, Ray worked as a medical director of a primary care clinic and in biologic product strategy at the J&J owned biotech company, Centocor. He then worked on the sell side at Citigroup, and for the next six years was a Partner and Analyst covering all of healthcare at Lee Munder Capital Group, a SMID cap investment firm in Boston. For the subsequent eight years, he ran a biotech portfolio at TIAA CREF and for the last three years he was Principal at Adenium Research, providing consulting services to biotech companies and buyside firms.
Ray received a Bachelor of Medical Science and an M.D. from the University of Alberta, with Honors in Research. He also graduated with an MBA from the University of Pennsylvania’s Wharton School, where he was a founder of an incubation phase bioinformatics startup, Genoma.